2022-01-01から1年間の記事一覧
" Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti … SA Antar, MA Saleh, AA Al-Karmalawy - Life Sciences, 2022 … It i…
" [HTML] Claims-based prevalence of disease progression among patients with fibrosing interstitial lung disease other than idiopathic pulmonary fibrosis in the United States D Singer, LGS Bengtson, CS Conoscenti, M Laouri… - Annals of the …
" [PDF] Targeting the DNM3OS/miR-199a~ 214 cluster for the treatment of fibroproliferative diseases F Brousseau, S Bellusci, M Perrais10, F Broly, P Barbry… … therapeutic target for refractory fibrotic diseases such as idiopathic pulmonary…
" [HTML] Extracellular vesicles in idiopathic pulmonary fibrosis: pathogenesis and therapeutics Y Fujita - Inflammation and Regeneration, 2022 … Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease that occurs due to increased…
" Modification of Micronized Drug Particles for Aerosolization T Bajaj, VP Kaur, U Anwekar, D Chitkara, C Singh - Organ Specific Drug Delivery and …, 2022 … 10 Inhalation or pulmonary delivery could be a better strategy to treat a variety …
" [HTML] Small airway dysfunction in Chinese patients with idiopathic pulmonary fibrosis X Zhang, B Xie, C Ban, Y Ren, Q Ye, M Zhu, Y Liu… - BMC Pulmonary Medicine, 2022 … Idiopathic pulmonary fibrosis (IPF), which is the most common form …
" [PDF] Elevated serum human epididymis protein 4 is associated with disease severity and worse survival in idiopathic pulmonary fibrosis: a cohort study M Tian, K Meng, Y Gao, J Zhang, M Xie, Y Tian, X Liu… - 2022 … Idiopathic pulmonary f…
" [PDF] The beneficial effect of Nintedanib in the COVID-19 patient with the complication of Idiopathic Pulmonary Fibrosis: A Case report. SM Besekar - IJCRHS| International Journal of Case Reports for …, 2022 … The greatest threat of seve…
" [HTML] Therapeutic effects of adipose-derived mesenchymal stem/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low … T Suzuka, T Kotani, T Saito, S Matsuda, T Sato… - Arthritis research & …, 2022 -…
" [PDF] A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases N Zozaya, MIA Basterrechea, E Bollo, I Castellví… - International Journal of …, 2022 … of nintedanib for non-idiopathic progressive fibros…
" [HTML] Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis A Kuzumi, A Yoshizaki, KM Matsuda, H Kotani… - Nature …, 2021 - nature.com … increased in fibrotic lungs of BLM-SSc mice 33 . Furthermore, … fibros…
" [PDF] Determining the role of the calcium-sensing receptor (CASR) in pulmonary fibrosis (PF) and the ability of a CASR inhibitor to reverse profibrotic changes in an in vitro … KL Wolffs - 2022 … Idiopathic pulmonary fibrosis (IPF) is a …
" [HTML] Inhibition of ferroptosis and iron accumulation alleviates pulmonary fibrosis in a bleomycin model Z Pei, Y Qin, X Fu, F Yang, F Huo, X Liang, S Wang… - Redox Biology, 2022 … Idiopathic pulmonary fibrosis (IPF) is a chronic progre…
" [HTML] Effects of nintedanib on disease progression and safety in Japanese patients with progressive fibrosing interstitial lung diseases: Further subset analysis from the … T Ogura, T Suda, N Inase, Y Nishioka, A Azuma… - Respiratory In…
" Incidence of acute exacerbation in patients with interstitial lung disease after COVID-19 vaccination M Sakayori, E Hagiwara, T Baba, H Kitamura, A Sekine… - Journal of Infection and …, 2022 … idiopathic pulmonary fibrosis (IPF) criteria…
" [HTML] Fighting fibrosis M Senior - Nature Biotechnology … Two recent sets of positive clinical data have bucked the trend in the failure-strewn idiopathic pulmonary fibrosis (IPF) field: BI’s phase 2 data for phosphodiesterase 4B (PDE4B…
" Pathological collagen targeting and penetrating liposomes for idiopathic pulmonary fibrosis therapy MY Yang, YJ Lin, MM Han, YY Bi, XY He, L Xing… - Journal of Controlled …, 2022 … Idiopathic pulmonary fibrosis (IPF) is a fibrotic inters…
" Polypharmacology in Clinical Applications: Respiratory Polypharmacology Z Wang, B Yang - Polypharmacology, 2022 … diseases include cystic fibrosis and idiopathic pulmonary fibrosis (IPF). IPF is characterized by a chronic progressive dec…
" [HTML] Inhibition of MAD2L1 Mediates Pulmonary Fibrosis through Impairment of Mitochondrial Function and Induction of Cell Senescence L Wang, R Wan, X Chen, X Guo, Z Li, W Zhao, P Yan… - Canadian Respiratory …, 2022 … In this study, we a…
" Elucidation of the Anti-Fibrotic Activity of a Repurposed Drug for Idiopathic Pulmonary Fibrosis J Reardon - 2022 … , has been identified as a potential novel therapy for IPF. Spironolactone is an off-patent drug for … Thus, we aimed to …
" Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis List of authors. Luca Richeldi, M.D., Ph.D., Arata Azuma, M.D., Ph.D., Vincent Cottin, M.D., Ph.D., Christian Hesslinger, Ph.D., Susanne Stowasser, …
" Serum proteomic profiling of rheumatoid arthritis–interstitial lung disease with a comparison to idiopathic pulmonary fibrosis X Wu, Y Jeong, SP de Frías, I Easthausen, K Hoffman… - Thorax, 2022 … Much of our knowledge regarding the path…
" Home monitoring in interstitial lung diseases MS Wijsenbeek, CC Moor, KA Johannson, PD Jackson… - The Lancet Respiratory …, 2022 … Disease behaviour is one of the most useful parameters for an accurate diagnosis of idiopathic pulmonary f…
" [HTML] Pimitespib, an HSP90 inhibitor, augments nifuroxazide-induced disruption in the IL-6/STAT3/HIF-1α autocrine loop in rats with bleomycin-challenged lungs … DH El-Kashef, ME Youssef, M Nasr, M Alrouji… - Biomedicine & …, 2022 … Idio…
" Fysisk aktivitet kan reducera dyspné vid KOL och lungfibros:[Exercise training can improve dyspnea among persons with COPD and IPF] M Emtner, M Nykvist, M Sköld, K Larsson, K Wadell - Läkartidningen, 2022 … obstructive pulmonary disease …
" [PDF] Extracellular HSP90α promotes cellular senescence by modulating TGF‐β signaling in pulmonary fibrosis W Zhong, W Chen, Y Liu, J Zhang, Y Lu, X Wan, Y Qiao… - The FASEB Journal, 2022 … Aging, especially cellular senescence, is a cri…
" Clinical differences among patients with myeloperoxidase–antineutrophil cytoplasmic antibody–positive interstitial lung disease K Yamaguchi, A Yamaguchi, M Ito, I Wakamatsu, M Itai… - Clinical Rheumatology, 2022 … Patients with ANCA-asso…
" [HTML] Assessment of diagnostic utility of serum hemeoxygenase-1 measurement for acute exacerbation of interstitial pneumonias Y Kata, Y Hara, Y Tagami, A Yabe, K Murohashi… - Scientific Reports, 2022 … of idiopathic pulmonary fibrosis (…
" [PDF] EVs-miRNA: The New Molecular Markers for Chronic Respiratory Diseases P Soccio, G Moriondo, D Lacedonia, P Tondo… - Life, 2022 … The main chronic respiratory diseases are asthma, chronic obstructive pulmonary disease (COPD), sleep …
" [HTML] Effects of bone morphogenetic protein 4 on TGF-β1-induced cell proliferation, apoptosis, activation and differentiation in mouse lung fibroblasts via ERK/p38 MAPK … Z Cai, H Guo, J Qian, W Liu, Y Li, L Yuan, Y Zhou, R Lin… - PeerJ…